Proprietary Chinese medicine preparations for curing chronic emphraxis lung diseases

Abstract

The invention provides a Chinese patent medicine preparation for treating chronic obstructive pulmonary disease, which comprises traditional Chinese medicine raw ingredients by weight proportions as follows: radix astragali is 30 to 50, ginseng 6 to 12, Salvia miltiorrhiza is 15 to 30, old arable soil is 20 to 50, ophiopogon roots are 10 20, and tuber pinellia is 6 to 10. The Chinese patent medicine preparation is prepared by the following method: the traditional Chinese medicine raw ingredients are obtained, crushed together, and processed into fine powders over 100 screen meshes according to the prescription, the fine powders are mixed uniformly and sterilized by ozone for 20 minutes to make dosage form of capsules, or the fine powders are added with honey and mixed uniformly to make the dosage form of pills. The Chinese patent medicine preparation is a pure TCM preparation, the traditional Chinese medicine raw ingredients are combined, and the purposes of replenishing spleen as well as lung and heart as well as kidney, eliminating phlegm stasis, and treating both cause and symptom are achieved; the Chinese patent medicine preparation has remarkable curative effect for treating the chronic obstructive pulmonary disease, simple production method, low cost, no obvious toxic and side effects, and easy acceptance by patients.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation for treating stable chronic obstructive pulmonary disease and a preparation method thereof, belonging to the technical field of traditional Chinese medicines. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is a lung disorder characterized by chronic, not fully reversible airflow limitation. The pathogenesis of COPD has not yet been fully elucidated. At present, it is believed that: airway inflammation, protease / anti-protease imbalance and oxidation / antioxidation imbalance play a major role in the pathogenesis of COPD. Inflammatory cell infiltration and inflammation caused by smoking or inhaling harmful substances The release of mediators is a key link in the pathogenesis of COPD. Research results in recent years have shown that interleukin-8 (IL-8) and tumor necrosis factor-α (TNF-α) are jointly involved in COPD airway inflammatory response and airway structure ...

AI Technical Summary

Problems solved by technology

However, the treatment is mainly based on decoctions, such as Sishen Xinmai Decoction, Yiqi Huoxue Huatan Decoction, etc., which are inconvenient to use and not conducive to long-term use; the existing patent medicines for COPD are less and most of them are single prescriptions, such as Ophiopogon japonicus extract Ophiopogon saponin D, Shengdi injection, etc., do not have the advantages of compound Chinese medicine interaction, enhanced efficacy, and supervision of toxicity